Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Cancers|April 3, 2021
Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (Results of the Planned Interim Analysis)Marcus Beck, Pirus Ghadjar, Felix Mehrhof, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 22, 2016
Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94)Pirus Ghadjar, Christoph Pöttgen, Daniela Joos, et al.
Radiation Oncology (London, England)|May 13, 2018
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectivesSebastian Zschaeck, Fabian Lohaus, Marcus Beck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2017
Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
JAMA Oncology|February 17, 2018
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical TrialRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|August 22, 2022
Tetramodal therapy with transurethral resection followed by chemoradiation in combination with hyperthermia for muscle-invasive bladder cancer: early results of a multicenter phase IIB studyOliver Riesterer, Adela Ademaj, Emsad Puric, et al.
European Urology Focus|July 21, 2017
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov DatabaseAlexandros Tsikkinis, Nikola Cihoric, Gianluca Giannarini, et al.
The Lancet. Oncology|May 4, 2010
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyRolf D Issels, Lars H Lindner, Jaap Verweij, et al.
European Urology|June 18, 2021
Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 TrialPirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10Pirus Ghadjar, Stefanie Hayoz, Jürg Bernhard, et al.
Pageof 25